Investors Contact Payment Careers Research Request Physician Portal
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Support
  • Lab
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request
  • Physician Portal

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts

Interpace Diagnostics Announces Agreement with ARUP Laboratories

Dec 18, 2017

Interpace Diagnostics Announces New York State Approval of New Product

Nov 16, 2017

Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

Nov 13, 2017

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017

Nov 9, 2017

Interpace Diagnostics Designated as “Company of the Month” by G2 Intelligence

Oct 25, 2017

Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017

Oct 23, 2017

Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®

Oct 18, 2017

Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference

Oct 17, 2017

Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®

Oct 11, 2017

Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test

Sep 25, 2017
RSS
    • 1...
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • ...24
    © 2025 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap Manage Cookie Preferences
    We Own Our Future Logo
    • Linkedin